4.6 Article

Bmi1 Regulates I kappa B alpha Degradation via Association with the SCF Complex

期刊

JOURNAL OF IMMUNOLOGY
卷 201, 期 8, 页码 2264-2272

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1701223

关键词

-

资金

  1. KAKENHI grant
  2. Takeda Science Foundation
  3. Institute for Fermentation Osaka
  4. Mitsubishi Foundation
  5. Waksman Foundation of Japan
  6. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  7. Takeshi Nagao Intractable Diseases Research Fund
  8. Tokyo Medical Research Foundation
  9. Japan Science and Technology Agency-Centers of Research Excellence in Science and Technology Program
  10. Osaka Foundation for the Promotion of Clinical Immunology

向作者/读者索取更多资源

Bmi1 is a polycomb group protein and regulator that stabilizes the ubiquitination complex PRC1 in the nucleus with no evidently direct link to the NF-kappa B pathway. In this study, we report a novel function of Bmi1: its regulation of I kappa B alpha ubiquitination in the cytoplasm. A deficiency of Bmi1 inhibited NF-kappa B-mediated gene expression in vitro and a NF-kappa B-mediated mouse model of arthritis in vivo. Mechanistic analysis showed that Bmi1 associated with the SCF ubiquitination complex via its N terminus and with phosphorylation by an IKK alpha/beta-dependent pathway, leading to the ubiquitination of I kappa B alpha . These effects on NF-kappa B-related inflammation suggest Bmi1 in the SCF complex is a potential therapeutic target for various diseases and disorders, including autoimmune diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据